Community/Retail

Valeant Pharmaceuticals International and Salix Pharmaceuticals have entered into an amendment to their Agreement and Plan of Merger, dated February 20, 2015.

IMBRUVICA is jointly developed and commercialized by Janssen Biotech, Inc, and Pharmacyclics, Inc.

Orexo has recently announced that the 8.6-mg/2.1-mg dosage strength of its partial opioid agonist, buprenorphine and naloxone (Zubsolv), is now available in the United States.

More than 90% of HIV transmissions originate from undiagnosed and untreated individuals. On the other hand, those retained in medical care who have achieved viral suppression are 94% less likely to transmit HIV.

From optimizing inhaler technique in patients with chronic obstructive pulmonary disease, to catching red flags when dispensing controlled substances to patients with chronic pain, pharmacists can improve patient outcomes in an evolving treatment landscape.

A pharmacist has been lauded by a judge for her efforts to help a domestic violence victim.

The American Academy of Neurology and the American Brain Foundation are awarding the 2015 Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases to Peter Davies, PhD, of the Feinstein Institute for Medical Research and Reisa A. Sperling, MD, of the Brigham and Women's Hospital and Massachusetts General Hospital.

Some researchers have proposed that vitamin E and selenium supplements may inhibit cataract formation.

Do drug take-back programs in pharmacies do more harm than good?

The National Institutes of Health today admitted an American healthcare worker who tested positive for Ebola virus while volunteering at an Ebola treatment unit in Sierra Leone.

Without allocating more funds toward human papillomavirus vaccinations, there may be better public health results if funds were devoted to vaccinating boys as well as girls.

What shapes an individual's thoughts on his or her health?

Following settlement of the sale, GSK will hold 28.2 million ordinary shares in Aspen, representing approximately 6.2% of the issued share capital.

Loved ones, friends, and health care providers of individuals whom they believe to be at risk of suicide will soon have access to new tools developed by Facebook and SAMHSA that will enable them to better help those in need.

The National Association of Boards of Pharmacy in conjunction with various other stakeholder organizations has recently released a consensus document titled "Stakeholders' Challenges and Red Flag Warning Signs Related to Prescribing and Dispensing Controlled Substances."

Baxter International Inc. announced positive results from its Phase III clinical trial evaluating the safety and efficacy of BAX 817, an investigational recombinant factor VIIa treatment for people with hemophilia A or B who develop inhibitors.

The National Community Pharmacists Association will hold its 2015 Annual Legislative Conference on May 12-13, 2015.

Children born to parents with bipolar disorder have a strong likelihood of experiencing episodes of manic symptoms themselves.

The FDA today approved the supplemental new drug application for asenapine (Saphris) as monotherapy for the acute treatment of manic or mixed episodes associated with bipolar I disorder for patients aged 10 to 17 years.

Mylan Inc. has introduced 3 generic versions of existing drugs to the US market, including the first and only available intermediate dosages of transdermal fentanyl.

The University of Georgia College of Pharmacy embraces a true family atmosphere while still offering the perks of a large, research-intensive university.

Taking multiple medications, having hypertension, and executing heavy labor at work are all associated with a lower sperm count among men attempting to conceive.

David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists, debunks what he thinks are the 3 biggest compounding pharmacy myths.